TPH1 and neoplasm: Silencing TPH1 expression slowed down tumor growth in an established mouse model, whereas treatment with TPH1 inhibitor alleviated tumor progression in an azoxymethane/dextran sodium sulphate (AOM/DSS)-induced colorectal cancer (CRC) mouse model.